Medical translations leader ForeignExchange Translations joins euroscript International

18 May 2015

The two companies are very complementary in the makeup of each firm’s client list, product and services offerings, and market penetration across key geographical areas within the life sciences industry. euroscript brings technology focus, a global presence and experience in enterprise regulated content, document and compliance management solutions, while ForeignExchange offers language-service expertise in the medical device and pharmaceutical markets with a strong global client base.

“We are so pleased and excited to welcome Andres Heuberger and his worldwide team to the euroscript family” said Mark Evenepoel, CEO of euroscript. “With the combined talents of our respective employees, and the integration of our technologies and services, our companies will be able to respond to a much wider array of customer needs. The acquisitions of ForeignExchange and Infotehna, the leading vendor of regulatory information, document and process management solutions, which euroscript acquired last year, creates a unique offering addressing the life sciences industry specific global challenges and enabling clients to ensure the quality, efficacy and safety of their products.”

Andres Heuberger, CEO for ForeignExchange, adds “We’re proud of our reputation, our clients and our many achievements. ForeignExchange has experienced impressive growth and this acquisition will fuel further growth while allowing us to remain focused on our clients’ diverse requirements.”

The combined companies will employ 1,700 full time employees globally spread throughout 23 countries. 

About ForeignExchange Translations, Inc.

Founded in 1998, ForeignExchange Translations leads the medical translation industry, partnering exclusively with medical device, pharmaceutical and biotech organizations throughout the world. With its international teams of doctors, scientists and linguists, ForeignExchange helps the world’s largest drug and device companies reduce time to market, comply with international regulations, avoid risks, and save lives. Current clients include global medical enterprises such as Johnson & Johnson, Abbott, Novartis, and St. Jude Medical. For more information, visit http://www.fxtrans.com